Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Tables)

v2.4.0.8
Segment Information (Tables)
6 Months Ended
Mar. 30, 2014
Notes to Financial Statements [Abstract]  
Revenues and EBT for reportable segments
The table below presents revenues and EBT for reportable segments (in millions):
 
QCT
 
QTL
 
QSI
 
Reconciling
Items
 
Total
For the three months ended:
 
 
 
 
 
 
 
 
 
March 30, 2014
 
 
 
 
 
 
 
 
 
Revenues
$
4,243

 
$
2,071

 
$

 
$
53

 
$
6,367

EBT
740

 
1,834

 
(39
)
 
(263
)
 
2,272

March 31, 2013*
 
 
 
 
 
 
 
 
 
Revenues
$
3,916

 
$
2,057

 
$

 
$
151

 
$
6,124

EBT
681

 
1,803

 
33

 
(381
)
 
2,136

 
 
 
 
 
 
 
 
 
 
For the six months ended:
 
 
 
 
 
 
 
 
 
March 30, 2014
 
 
 
 
 
 
 
 
 
Revenues
$
8,859

 
$
3,971

 
$

 
$
159

 
$
12,989

EBT
1,646

 
3,504

 
(35
)
 
(1,086
)
 
4,029

March 31, 2013*
 
 
 
 
 
 
 
 
 
Revenues
$
8,036

 
$
3,813

 
$

 
$
294

 
$
12,143

EBT
1,749

 
3,335

 
16

 
(637
)
 
4,463


Reconciling items for reportable segments - revenues
Reconciling items in the previous table were as follows (in millions):
 
Three Months Ended
 
Six Months Ended
 
March 30,
2014
 
March 31, 2013*
 
March 30,
2014
 
March 31, 2013*
Revenues
 
 
 
 
 
 
 
Nonreportable segments
$
53

 
$
152

 
$
162

 
$
296

Intersegment eliminations

 
(1
)
 
(3
)
 
(2
)
 
$
53

 
$
151

 
$
159

 
$
294

EBT
 
 
 
 
 
 
 
Unallocated cost of equipment and services revenues
$
(75
)
 
$
(93
)
 
$
(148
)
 
$
(177
)
Unallocated research and development expenses
(217
)
 
(204
)
 
(434
)
 
(389
)
Unallocated selling, general and administrative expenses
(85
)
 
(153
)
 
(210
)
 
(264
)
Unallocated other expense

 

 
(12
)
 

Unallocated investment income, net
314

 
220

 
571

 
468

Nonreportable segments
(200
)
 
(151
)
 
(853
)
 
(275
)
 
$
(263
)
 
$
(381
)
 
$
(1,086
)
 
$
(637
)

Reconciling items for reportable segments - EBT
Reconciling items in the previous table were as follows (in millions):
 
Three Months Ended
 
Six Months Ended
 
March 30,
2014
 
March 31, 2013*
 
March 30,
2014
 
March 31, 2013*
Revenues
 
 
 
 
 
 
 
Nonreportable segments
$
53

 
$
152

 
$
162

 
$
296

Intersegment eliminations

 
(1
)
 
(3
)
 
(2
)
 
$
53

 
$
151

 
$
159

 
$
294

EBT
 
 
 
 
 
 
 
Unallocated cost of equipment and services revenues
$
(75
)
 
$
(93
)
 
$
(148
)
 
$
(177
)
Unallocated research and development expenses
(217
)
 
(204
)
 
(434
)
 
(389
)
Unallocated selling, general and administrative expenses
(85
)
 
(153
)
 
(210
)
 
(264
)
Unallocated other expense

 

 
(12
)
 

Unallocated investment income, net
314

 
220

 
571

 
468

Nonreportable segments
(200
)
 
(151
)
 
(853
)
 
(275
)
 
$
(263
)
 
$
(381
)
 
$
(1,086
)
 
$
(637
)

*As adjusted
Nonreportable segments EBT for the six months ended March 30, 2014 included a total of $460 million in impairment charges related to the Company’s QMT and QRS divisions (Note 9).
Unallocated acquisition-related expenses were comprised as follows (in millions):
 
Three Months Ended
 
Six Months Ended
 
March 30,
2014
 
March 31,
2013
 
March 30,
2014
 
March 31,
2013
Cost of equipment and services revenues
$
62

 
$
76

 
$
123

 
$
140

Research and development expenses
22

 
1

 
23

 
1

Selling, general and administrative expenses
6

 
6

 
13

 
13

Segment assets and reconciling items
Segment assets and reconciling items were as follows (in millions):
 
March 30,
2014
 
September 29, 2013*
QCT
$
3,141

 
$
3,305

QTL
157

 
28

QSI
461

 
511

Reconciling items
44,116

 
41,672

Total consolidated assets
$
47,875

 
$
45,516

*As adjusted